Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Observe Medical ASA ( (DE:OM50) ) has provided an announcement.
Observe Medical ASA has announced that the Norwegian Financial Supervisory Authority (NFSA) has upheld its preliminary decision regarding the company’s financial reporting errors. The company will make several corrections in its 2024 Annual Report, including adjustments to goodwill write-downs, capitalized expenses, and the allocation of consideration for the Convatec transaction. These changes will not affect the company’s revenues, gross margin, or liquidity, but may lead to additional impairments as the company finalizes its 2024 financial statements.
More about Observe Medical ASA
Observe Medical is a Nordic medtech company based in Oslo, Norway, specializing in the development, marketing, and sales of innovative medical technology products globally. The company focuses on improving patient welfare and outcomes, enhancing clinical data accuracy, and promoting positive health economics, with a strong emphasis on urine measurement and ultrasound technologies.
Average Trading Volume: 91,871
Current Market Cap: NOK30.62M
See more insights into OM50 stock on TipRanks’ Stock Analysis page.